SSE Ticker: 688278

Xiamen Amoytop Biotech Co., Ltd.

特宝生物

Authorized Representative: 兰春

Board: Star Market

Industry Classification: Biomedicine

Tebao Bio (688278): Investor Relations Activity Record Form CFi.CN Zhongcai Network

Post date May 10, 2022 — 23:16 Post Lock

[Transaction stock] The hepatitis concept sector fell, and Shuangcheng Pharmaceutical (002693.CN) fell 6.63%-Hong Kong Stocks-Financial

Post date May 9, 2022 — 12:30 Post Lock

Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research

Post date May 9, 2022 — 02:16 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 17:33 Post Lock

Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews

Post date May 8, 2022 — 15:50 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune

Post date May 8, 2022 — 15:37 Post Lock

Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 13:24 Post Lock

Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research

Post date May 8, 2022 — 13:23 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards.

Post date May 7, 2022 — 07:56 Post Lock

4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com

Post date April 29, 2022 — 20:30 Post Lock

Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com

Post date April 29, 2022 — 18:25 Post Lock

On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

Post date April 29, 2022 — 16:12 Post Lock

First quarter results plummeted! "Glove Mao" Inke Medical thwarted the concept of hepatitis but quietly rose! Shuangcheng Pharmaceutical 4 consecutive boards_ Oriental Fortune Net

Post date April 29, 2022 — 14:54 Post Lock

Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities

Post date April 21, 2022 — 09:05 Post Lock

Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out?

Post date April 21, 2022 — 09:05 Post Lock

Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com

Post date April 21, 2022 — 09:03 Post Lock

April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net

Post date April 20, 2022 — 19:11 Post Lock

Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing cost of new crown oral drugs – yqqlm

Post date April 20, 2022 — 15:04 Post Lock

Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm

Post date April 20, 2022 — 15:02 Post Lock

Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm

Post date April 20, 2022 — 15:02 Post Lock

Want to see more data? Registered subscribers can see all the data.